BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

67 related articles for article (PubMed ID: 20495443)

  • 21. Paraganglion of the prostate in a needle biopsy: a potential diagnostic pitfall.
    Kawabata K
    Arch Pathol Lab Med; 1997 May; 121(5):515-6. PubMed ID: 9167608
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diffuse p63 positivity in prostate cancer: a mimic of prostatic atrophy.
    Rao P; Dwyer M; Mikel J; Varma M
    Histopathology; 2012 Apr; 60(5):847-8. PubMed ID: 22260619
    [No Abstract]   [Full Text] [Related]  

  • 23. Fine needle aspiration biopsy for diagnosis and follow-up of prostate cancer. Consensus Conference on Diagnosis and Prognostic Parameters in Localized Prostate Cancer. Stockholm, Sweden, May 12-13, 1993.
    Andersson L; Hagmar B; Ljung BM; Skoog L
    Scand J Urol Nephrol Suppl; 1994; 162():43-9; discussion 115-27. PubMed ID: 7817160
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Needle biopsies of the prostate: what constitutes adequate histologic sampling?
    Lane RB; Lane CG; Mangold KA; Johnson MH; Allsbrook WC
    Arch Pathol Lab Med; 1998 Sep; 122(9):833-5. PubMed ID: 9740145
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Diagnosis based on prostate needle biopsy: inadequate correlation between pathologic results and clinical course for individual prognosis].
    van der Kwast TH; Hoedemaeker RF; Schröder FH
    Ned Tijdschr Geneeskd; 2005 Apr; 149(18):972-6. PubMed ID: 15903037
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Diagnostic utility of a p63/alpha-methyl coenzyme A racemase (p504s) cocktail in ambiguous lesions of the prostate upon needle biopsy.
    Molinié V; Hervé JM; Lugagne PM; Lebret T; Botto H
    BJU Int; 2006 May; 97(5):1109-15. PubMed ID: 16643500
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Diagnostic effect of an improved preembedding method of prostate needle biopsy specimens.
    Rogatsch H; Moser P; Volgger H; Horninger W; Bartsch G; Mikuz G; Mairinger T
    Hum Pathol; 2000 Sep; 31(9):1102-7. PubMed ID: 11014578
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Usefulness of basal cell cocktail (34betaE12 + p63) in the diagnosis of atypical prostate glandular proliferations.
    Shah RB; Kunju LP; Shen R; LeBlanc M; Zhou M; Rubin MA
    Am J Clin Pathol; 2004 Oct; 122(4):517-23. PubMed ID: 15487448
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Patient with disseminated intravascular coagulation as the first manifestation of adenocarcinoma of the prostate. Risks of prostatic biopsy.
    Navarro M; Ruiz I; Martín G; Cruz JJ
    Prostate Cancer Prostatic Dis; 2006; 9(2):190-1. PubMed ID: 16331297
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prostate adenocarcinoma detected after high-grade prostatic intraepithelial neoplasia or atypical small acinar proliferation.
    López JI
    BJU Int; 2007 Dec; 100(6):1272-6. PubMed ID: 17850386
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The focus of "atypical glands, suspicious for malignancy" in prostatic needle biopsy specimens.
    Arista-Nasr J; Keirns C
    Am J Clin Pathol; 1998 Sep; 110(3):409. PubMed ID: 9728620
    [No Abstract]   [Full Text] [Related]  

  • 32. ASAP. Atypical small acinar proliferations.
    Wightman HR
    Hum Pathol; 1999 Dec; 30(12):1403; author reply 1404. PubMed ID: 10667414
    [No Abstract]   [Full Text] [Related]  

  • 33. ASAP. Atypical small acinar proliferations.
    Rosen S; Upton M
    Hum Pathol; 1999 Dec; 30(12):1403; author reply 1404. PubMed ID: 10667413
    [No Abstract]   [Full Text] [Related]  

  • 34. ASAP is a valid diagnosis. Atypical small acinar proliferation.
    Iczkowski KA; Cheng L; Qian J; Shanks J; Gadaleanu V; Bostwick DG; Ramnani DM
    Hum Pathol; 1999 Dec; 30(12):1403-4. PubMed ID: 10667415
    [No Abstract]   [Full Text] [Related]  

  • 35. Adenocarcinoma of the prostate: diagnostic techniques.
    Waisman J
    Hum Pathol; 1992 Oct; 23(10):1194-5. PubMed ID: 1398651
    [No Abstract]   [Full Text] [Related]  

  • 36. WHO International Consultation on Prostate Cancer: a summary.
    Albertsen PC
    Acta Oncol; 2011 Jun; 50 Suppl 1():155-60. PubMed ID: 21166604
    [No Abstract]   [Full Text] [Related]  

  • 37. New possibilities for urinary molecular diagnostics.
    Culig Z
    BJU Int; 2016 Apr; 117(4):547-8. PubMed ID: 26969032
    [No Abstract]   [Full Text] [Related]  

  • 38. Adductor myonecrosis following prostate biopsy.
    Braslis KG; Stephens DA
    Aust N Z J Surg; 1997 Dec; 67(12):900-2. PubMed ID: 9451351
    [No Abstract]   [Full Text] [Related]  

  • 39. The natural history: how has prostate cancer trend modified?
    Schiaffino E
    Arch Ital Urol Androl; 2005 Jun; 77(3):167-8. PubMed ID: 16372513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Clinical management of stage A1 adenocarcinoma of prostate gland.
    Harrison RH
    Urology; 1983 Apr; 21(4):437. PubMed ID: 6836844
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.